pyrimidine has been researched along with 2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardalan, K; Cleaveland, ES; Cooney, DA; Ford, H; Monks, A; Paull, K; Vaigro-Wolff, A; Zaharevitz, DW | 1 |
| Gabuzda, D; Lucile White, E; Mankowski, MK; Miranda Nebane, N; Misra, V; Pery, E; Ptak, RG; Rasmussen, L; Sheehy, A | 1 |
2 other study(ies) available for pyrimidine and 2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid
| Article | Year |
|---|---|
Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program.
Topics: Aminobiphenyl Compounds; Antineoplastic Agents; Binding Sites; Biphenyl Compounds; Cell Division; Dihydroorotate Dehydrogenase; Humans; Imidazoles; Naphthoquinones; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidines; Software; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.
Topics: Aminobiphenyl Compounds; Antiviral Agents; APOBEC-3G Deaminase; Cells, Cultured; Cytidine Deaminase; Enzyme Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Phenazines; Pyrimidines; Virus Replication | 2015 |